Related references
Note: Only part of the references are listed.Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment
Yoav Nahum et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Letter regarding Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
Manuel Jorge Rial et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Conjunctivitis in dupilumab clinical trials
B. Akinlade et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Ocular Co-Morbidities of Atopic Dermatitis. Part I: Associated Ocular Diseases
Kristen M. Beck et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
Lina U. Ivert et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
Andreas Wollenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis
Alison D. Treister et al.
JAMA DERMATOLOGY (2018)
Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis
Jacob P. Thyssen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al.
LANCET (2017)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Maurizio Mennini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Atopic dermatitis phenotypes and the need for personalized medicine
Beatriz Cabanillas et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Current Understanding in Pathogenesis of Atopic Dermatitis
Tess McPherson
INDIAN JOURNAL OF DERMATOLOGY (2016)
Drug evaluation review: dupilumab in atopic dermatitis
Jennifer D. Hamilton et al.
IMMUNOTHERAPY (2015)
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
Jennifer D. Hamilton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Atopic Dermatitis and Keratoconjunctivitis
Brett Bielory et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2010)
Share Paper
